한글목차

심장 제세동기 시장은 2030년까지 229억 달러에 달할 전망입니다.

2023년에 134억 달러로 평가된 심장 제세동기 시장은 2030년에는 229억 달러에 이를 전망이며, 예측 기간 동안 복합 연간 성장률(CAGR) 7.9%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 이식형/미국 내 심장 제세동기는 복합 연간 성장률(CAGR) 6.1%로 성장을 지속하고, 분석 기간 종료까지 123억 달러에 달할 것으로 예측됩니다. 체외 제세동기 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 10.5%로 추정됩니다.

미국 시장은 36억 달러를 나타낼 전망이며 중국은 복합 연간 성장률(CAGR) 7.5%로 성장할 것으로 예측됩니다.

미국의 심장 제세동기 시장은 2023년 36억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 36억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR) 7.5%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 6.9%와 6.8%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 6.3%로 성장할 것으로 예측됩니다.

세계 심장 제세동기 시장 - 주요 동향과 촉진요인 요약

심장 제세동기는 심부정맥, 특히 심실 세동 및 심실 빈맥의 치료에 사용되는 중요한 의료기기입니다. 몇 가지 중요한 요소가 심장 제세동기 시장의 성장을 뒷받침하고 있습니다. 심장 마비와 뇌졸중과 같은 심혈관 질환(CVD)의 유병률 증가는 제세동기 수요를 크게 밀어 올립니다. 세계보건기구(WHO)는 CVD를 세계 사망의 1위로 삼고 있습니다. 기술의 진보도 중요한 역할을 하고 있으며, 무선 연결, 원격 모니터링, 보다 컴팩트한 설계 등의 기술 혁신으로 제세동기는 점점 효과적이고 사용하기 쉬워지고 있습니다. 최신 이식형 제세동기는 수명이 길고 데이터 보고도 개선되었습니다.

CVD에 걸리기 쉬운 노인 인구가 증가함에 따라 고급 건강 관리 솔루션이 필요하며 제세동기 수요가 더욱 증가하고 있습니다. 또한, 제세동기, 특히 자동 체외식 제세동기(AED)의 사용을 촉진하는 의식 향상,훈련 프로그램에 의해 공공장소에서의 구명 기기에의 액세스가 향상하고 있습니다. 정부의 이니셔티브와 자금 지원은 의료 시설 전체에의 도입을 지원하고, 헬스 케어 인프라에 대한 투자 증가와 아시아태평양이나 라틴아메리카 등의 신흥 시장에서의 의식의 고조는 성장을 가속합니다.

인공지능(AI)과 사물인터넷(IoT)을 제세동기에 통합함으로써 예지보전, 실시간 모니터링, 연결이 가능합니다. 인공지능(AI)은 제세동기의 동작에 크게 영향을 미치며, 구명 치료를 강화하는 머신러닝 알고리즘을 통해 제세동기를 더욱 효율적으로 만듭니다. 웨어러블 제세동기는 이식 가능한 장치를 기다리는 환자를 위한 비침습적이고 일시적인 솔루션으로 널리 사용되고 있습니다. 피하 내장형 제세동기(S-ICD)는 침습성이 낮기 때문에 감염 위험이 줄어들고 인기를 끌고 있습니다. 또한 스마트 모니터링은 환자의 지속적인 실시간 모니터링과 의료 제공업체 간의 데이터 공유를 가능하게 합니다.

조사 대상 기업 예(전 48건)

• Abbott Laboratories
• Biotronik GmbH & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• GE Healthcare Ltd.
• Medtronic, Inc.
• Philips Healthcare
• Physio-Control Inc.
• St. Jude Medical Inc.
• Zoll Medical Corporation

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Cardiac Defibrillators Market to Reach US$22.9 Billion by 2030

The global market for Cardiac Defibrillators estimated at US$13.4 Billion in the year 2023, is expected to reach US$22.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Implantable / Internal Cardiac Defibrillator, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the External Cardiac Defibrillator segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.5% CAGR

The Cardiac Defibrillators market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Global Cardiac Defibrillators Market - Key Trends and Drivers Summarized

Cardiac defibrillators are essential medical devices used to treat cardiac arrhythmias, especially ventricular fibrillation and ventricular tachycardia. Several significant factors drive the growth of the cardiac defibrillator market. The increasing prevalence of cardiovascular diseases (CVDs), such as heart attacks and strokes, significantly boosts demand for defibrillators. The World Health Organization identifies CVDs as the leading cause of death worldwide. Technological advancements also play a critical role, with innovations like wireless connectivity, remote monitoring, and more compact designs making defibrillators increasingly effective and user-friendly. The latest implantable devices offer better longevity and improved data reporting.

The growing geriatric population, which is more susceptible to CVDs, requires advanced healthcare solutions, further fueling the demand for defibrillators. In addition, awareness and training programs that promote the use of defibrillators, especially automated external defibrillators (AEDs), increase accessibility to these life-saving devices in public spaces. Government initiatives and funding support their adoption across healthcare facilities, while rising investments in healthcare infrastructure and growing awareness in emerging markets such as Asia-Pacific and Latin America spur growth.

The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments.  Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.

Select Competitors (Total 48 Featured) -

• Abbott Laboratories
• Biotronik GmbH & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• GE Healthcare Ltd.
• Medtronic, Inc.
• Philips Healthcare
• Physio-Control Inc.
• St. Jude Medical Inc.
• Zoll Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Cardiac Defibrillators - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Global Prevalence of Cardiovascular Diseases Drives Demand for Cardiac Defibrillators
  • Technological Advancements in Implantable Cardioverter Defibrillators (ICDs) Propel Market Growth
  • Expansion of Public Access Defibrillation Programs Expands Addressable Market Opportunities
  • Aging Population Worldwide Strengthens Business Case for Advanced Cardiac Therapies
  • Rising Health Awareness and Preventive Care Trends Accelerate Adoption of External Defibrillators
  • Integration of Remote Monitoring with Cardiac Defibrillators Enhances Patient Management
  • Miniaturization and Battery Improvement Catalyze Innovations in Defibrillator Design
  • Emergence of Smart Defibrillators with AI Capabilities Generates Market Interest
  • Emerging Markets Present Growth Opportunities Due to Expanding Healthcare Infrastructure
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cardiac Defibrillators Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cardiac Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cardiac Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Implantable / Internal Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Implantable / Internal Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Implantable / Internal Cardiac Defibrillator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for External Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for External Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for External Cardiac Defibrillator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Public Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Public Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Public Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Defibrillators by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Cardiac Defibrillators by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Cardiac Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Rest of Europe Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Rest of Europe 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Rest of Europe 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Cardiac Defibrillators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Asia-Pacific Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Asia-Pacific 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of World Historic Review for Cardiac Defibrillators by Product Segment - Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of World 16-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable / Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2014, 2024 & 2030
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of World 16-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION